Juan Carlos
Montero González
Researcher from 2021
Instituto Canario de Investigación del Cáncer
Santa Cruz de Tenerife, EspañaPublications in collaboration with researchers from Instituto Canario de Investigación del Cáncer (4)
2023
-
Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer
International Journal of Biological Sciences, Vol. 19, Núm. 6, pp. 1731-1747
2017
-
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia
Oncotarget, Vol. 8, Núm. 18, pp. 29679-29698
2010
-
Enhancement of antiproliferative activity by molecular simplification of catalpol
Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 7, pp. 2515-2523
-
Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors
Journal of Medicinal Chemistry, Vol. 53, Núm. 9, pp. 3835-3839